Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. Revenue 2018–2025
Cue Biopharma, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cue Biopharma, Inc. revenue for the quarter ending March 31, 2026 was 5.7 M, a 1250.59% increase year-over-year.
- Cue Biopharma, Inc. revenue for the twelve months ending March 31, 2026 was 11.2 M, a 14.26% increase year-over-year.
- Cue Biopharma, Inc. annual revenue for 2025 was 27.5 M, a 195.75% increase from 2024.
- Cue Biopharma, Inc. annual revenue for 2024 was 9.3 M, a 69.16% increase from 2023.
- Cue Biopharma, Inc. annual revenue for 2023 was 5.5 M, a 340.96% increase from 2022.
- Cue Biopharma, Inc. annual revenue for 2022 was 1.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cue Biopharma, Inc. Market Cap — FAQ
Cue Biopharma, Inc. (CUE) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's market cap history?
The chart and table above show Cue Biopharma, Inc.'s market cap by year and by quarter, including the growth rate.